Related Experiment Video
Updated: Aug 16, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
Enhancement of CPP32-like activity in the TNF-treated U937 cells by the proteasome inhibitors
E Fujita1, T Mukasa, T Tsukahara
1Division of Development and Differentiation, NCNP, Tokyo, Japan.
Abstract:
CPP32, which is most closely related to CED-3 in the apoptotic protease in C. elegance, is activated during apoptosis induced by anti-Fas and TNF. Since processing of CPP32 is important for the activation, we examined the effects of protease inhibitors on CPP32-like activity in the TNF-treated U937 cells. Unexpectedly, proteasome inhibitors (at 5 microM) such as Z-LLnV, Z-LLL, and lactacystin enhanced CPP32-like activity, Ac-DEVD-MCA degrading activity, in the TNF-treated U937 cells in 3 hr, but E64d, cysteine protease inhibitor, did not. These proteasome inhibitors alone did not enhance CPP32-like activity in the untreated U937 cells under the condition used. The proteasome seems to protect the cells from apoptosis by degrading CPP32-like protease or its processing enzyme.
Insights
Proteasome inhibitors unexpectedly enhanced CPP32-like activity during apoptosis in U937 cells. This suggests the proteasome normally degrades CPP32-like proteases, protecting cells from apoptosis.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- CPP32 is a protease crucial for apoptosis, structurally similar to C. elegans CED-3.
- CPP32 activation is essential for apoptosis induced by anti-Fas and TNF.
- Protease inhibitors were used to investigate CPP32-like activity regulation.
Purpose of the Study:
- To examine the effects of protease inhibitors on CPP32-like activity in TNF-treated U937 cells.
- To understand the role of proteasomes in regulating CPP32-like protease activity and apoptosis.
Main Methods:
- U937 cells were treated with TNF to induce apoptosis.
- Cells were treated with various protease inhibitors, including proteasome inhibitors (Z-LLnV, Z-LLL, lactacystin) and a cysteine protease inhibitor (E64d).
- CPP32-like activity was measured by Ac-DEVD-MCA degrading activity.
Main Results:
- Proteasome inhibitors significantly enhanced CPP32-like activity in TNF-treated U937 cells.
- The cysteine protease inhibitor E64d did not enhance this activity.
- Proteasome inhibitors alone did not affect CPP32-like activity in untreated U937 cells.
Conclusions:
- The proteasome appears to play a protective role against apoptosis by degrading CPP32-like proteases or their processing enzymes.
- Inhibition of the proteasome leads to increased CPP32-like protease activity, potentially promoting apoptosis.
- These findings highlight a novel regulatory mechanism of apoptosis involving proteasome-mediated degradation of key apoptotic proteases.
Related Concept Videos
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Abnormal Proliferation
The Unfolded Protein Response
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Anaphase Promoting Complex
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...

